IPO Landscape Favorable for Orthopedic Players

In the wake of the COVID-19 pandemic, attractive valuations and abundantly available capital have led to record numbers of initial public offerings (IPOs). Additionally, opportunities to benefit from market disruption have made companies hungry for capital infusions. In 2019, Nasdaq had 124 IPOs that raised $24 billion for the entire year....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us